vs
CRYO CELL INTERNATIONAL INC（CCEL）与MANGOCEUTICALS, INC.（MGRX）财务数据对比。点击上方公司名可切换其他公司
CRYO CELL INTERNATIONAL INC的季度营收约是MANGOCEUTICALS, INC.的83.1倍（$7.8M vs $94.4K）。CRYO CELL INTERNATIONAL INC净利率更高（-48.7% vs -2935.1%，领先2886.4%）。CRYO CELL INTERNATIONAL INC同比增速更快（-2.3% vs -10.3%）。过去两年CRYO CELL INTERNATIONAL INC的营收复合增速更高（-0.1% vs -33.6%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
MANGOCEUTICALS INC是一家专注男士健康护理的企业，研发销售经科学验证的膳食补充剂、男士护肤及护发产品，主要面向美国市场，通过直营电商平台及精选零售渠道为成年男性提供便捷透明的健康护理解决方案。
CCEL vs MGRX — 直观对比
营收规模更大
CCEL
是对方的83.1倍
$94.4K
营收增速更快
CCEL
高出8.1%
-10.3%
净利率更高
CCEL
高出2886.4%
-2935.1%
两年增速更快
CCEL
近两年复合增速
-33.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $94.4K |
| 净利润 | $-3.8M | $-2.8M |
| 毛利率 | 77.9% | 50.3% |
| 营业利润率 | -50.6% | -389.7% |
| 净利率 | -48.7% | -2935.1% |
| 营收同比 | -2.3% | -10.3% |
| 净利润同比 | -105.1% | -42.1% |
| 每股收益（稀释后） | $-0.46 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELMGRX
| Q4 25 | $7.8M | $94.4K | ||
| Q3 25 | $7.8M | $84.2K | ||
| Q2 25 | $7.9M | $168.1K | ||
| Q1 25 | $8.0M | $109.3K | ||
| Q4 24 | $8.0M | $105.2K | ||
| Q3 24 | $8.1M | $133.4K | ||
| Q2 24 | $8.0M | $163.2K | ||
| Q1 24 | $7.9M | $214.1K |
净利润CCELMGRX
| Q4 25 | $-3.8M | $-2.8M | ||
| Q3 25 | $749.4K | $-7.6M | ||
| Q2 25 | $355.8K | $-5.4M | ||
| Q1 25 | $282.9K | $-4.8M | ||
| Q4 24 | $-1.9M | $-1.9M | ||
| Q3 24 | $1.1M | $-2.0M | ||
| Q2 24 | $655.8K | $-2.4M | ||
| Q1 24 | $556.2K | $-2.4M |
毛利率CCELMGRX
| Q4 25 | 77.9% | 50.3% | ||
| Q3 25 | 77.0% | 60.4% | ||
| Q2 25 | 76.6% | 53.5% | ||
| Q1 25 | 75.1% | 56.8% | ||
| Q4 24 | 78.4% | 76.1% | ||
| Q3 24 | 73.6% | 62.0% | ||
| Q2 24 | 74.8% | 42.8% | ||
| Q1 24 | 73.7% | 68.8% |
营业利润率CCELMGRX
| Q4 25 | -50.6% | -389.7% | ||
| Q3 25 | 24.3% | -8953.5% | ||
| Q2 25 | 18.8% | -3134.0% | ||
| Q1 25 | 13.3% | -4440.0% | ||
| Q4 24 | -1.5% | -1594.0% | ||
| Q3 24 | 17.2% | -1318.2% | ||
| Q2 24 | 17.3% | -1329.1% | ||
| Q1 24 | 10.5% | -1105.9% |
净利率CCELMGRX
| Q4 25 | -48.7% | -2935.1% | ||
| Q3 25 | 9.6% | -9042.8% | ||
| Q2 25 | 4.5% | -3221.6% | ||
| Q1 25 | 3.5% | -4427.4% | ||
| Q4 24 | -23.2% | -1851.2% | ||
| Q3 24 | 13.0% | -1499.0% | ||
| Q2 24 | 8.2% | -1465.4% | ||
| Q1 24 | 7.1% | -1105.9% |
每股收益（稀释后）CCELMGRX
| Q4 25 | $-0.46 | $0.38 | ||
| Q3 25 | $0.09 | $-0.69 | ||
| Q2 25 | $0.04 | $-0.57 | ||
| Q1 25 | $0.03 | $-1.29 | ||
| Q4 24 | $-0.23 | $-0.79 | ||
| Q3 24 | $0.13 | $-1.14 | ||
| Q2 24 | $0.08 | $-1.37 | ||
| Q1 24 | $0.07 | $-1.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $1.5M |
| 总债务越低越好 | $8.4M | — |
| 股东权益账面价值 | $-18.6M | $15.2M |
| 总资产 | $61.7M | $16.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCELMGRX
| Q4 25 | $3.3M | $1.5M | ||
| Q3 25 | $3.2M | $481.3K | ||
| Q2 25 | $4.4M | $101.0K | ||
| Q1 25 | $3.5M | $76.5K | ||
| Q4 24 | $3.5M | $58.7K | ||
| Q3 24 | $2.1M | $73.9K | ||
| Q2 24 | $1.5M | $490.2K | ||
| Q1 24 | $979.6K | $15.3K |
总债务CCELMGRX
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
股东权益CCELMGRX
| Q4 25 | $-18.6M | $15.2M | ||
| Q3 25 | $-14.8M | $15.7M | ||
| Q2 25 | $-15.6M | $19.2M | ||
| Q1 25 | $-14.7M | $20.3M | ||
| Q4 24 | $-13.2M | $13.9M | ||
| Q3 24 | $-9.6M | $13.4M | ||
| Q2 24 | $-10.7M | $13.8M | ||
| Q1 24 | $-10.3M | $-958.4K |
总资产CCELMGRX
| Q4 25 | $61.7M | $16.1M | ||
| Q3 25 | $63.2M | $16.5M | ||
| Q2 25 | $64.4M | $20.8M | ||
| Q1 25 | $64.4M | $21.8M | ||
| Q4 24 | $64.7M | $15.4M | ||
| Q3 24 | $62.9M | $14.8M | ||
| Q2 24 | $62.6M | $15.2M | ||
| Q1 24 | $61.7M | $301.4K |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $-1.1M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | — |
| 自由现金流率自由现金流/营收 | 15.5% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.2M | — |
8季度趋势，按日历期对齐
经营现金流CCELMGRX
| Q4 25 | $1.3M | $-1.1M | ||
| Q3 25 | $2.5M | $-1.2M | ||
| Q2 25 | $707.0K | $-1.3M | ||
| Q1 25 | $954.1K | $-2.3M | ||
| Q4 24 | $2.2M | $-1.1M | ||
| Q3 24 | $2.4M | $-1.2M | ||
| Q2 24 | $1.8M | $-1.6M | ||
| Q1 24 | $-356.9K | $-991.1K |
自由现金流CCELMGRX
| Q4 25 | $1.2M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $644.6K | — | ||
| Q1 25 | $892.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
自由现金流率CCELMGRX
| Q4 25 | 15.5% | — | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
资本支出强度CCELMGRX
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
现金转化率CCELMGRX
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
